Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Thomas Li, Sr Director at Roche to Speak at 3rd Oncology Biomarkers Conference on January 27-28 San Diego, California - Thomas Li, Senior Director of Technology Management and US Chief Technology Officer at Hoffmann - La Roche to give a presentation on “Oncology Biomarker Discovery Technologies of Today and Tomorrow” at GTCbio’s 3rd Oncology Biomarkers Conference
Thomas Li, Sr Director at Roche to Speak at 3rd Oncology Biomarkers Conference on January 27-28 San Diego, California

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2010/11/26 - Thomas Li, Senior Director of Technology Management and US Chief Technology Officer at Hoffmann - La Roche to give a presentation on “Oncology Biomarker Discovery Technologies of Today and Tomorrow” at GTCbio’s 3rd Oncology Biomarkers Conference.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Thomas Li, Senior Director of Technology Management and US Chief Technology Officer at Hoffmann - La Roche to give a presentation on “Oncology Biomarker Discovery Technologies of Today and Tomorrow” at GTCbio’s 3rd Oncology Biomarkers Conference on January 27-28, 2011 in San Diego, CA

Dr. Li will review the past and present biomarker discovery technologies. Technology examples will be drawn from genomics, proteomics, glycomics, metabolomics and cellular analysis. Topics will include microarray, amplification, melting curve analysis, immunoassay, autoantibodies, antibody technology, multiplexing, mass spectrometry, immunohistochemistry, in situ hybridization, comparative genomic hybridization, copy number variation, sequencing, flow cytometry, digital imaging, bioinformatics and pathway analysis. Advances in automation, workflow and sample prep will also be covered. Finally future direction of biomarker discovery technologies will also be projected.

Attendees will gain understanding on:

• The past and present biomarker technologies;
• Current limitation of biomarker technologies;
• Examples of biomarker discovery success story;
• Future direction of biomarker technology development;
• History of Biomarker Discovery Technologies;
• Overview of the current state-of-the-art Biomarker discovery Technologies;
• Unmet need of biomarker discovery technologies will also be discussed.

Dr. Li rose through the scientific and managerial ranks of Rx and DX companies such as Miles Laboratories (Bayer), Syntex (Roche), Hycor (Strategene/Agilent), and the Diagnostic Products Corporation (Siemens), before joining Invitrogen (ABI) and then Roche.

Dr. Li is a member of ASCO and AACR, a Fellow of the American Academy of Allergy, Asthma and Immunology, a Fellow of the Association of Clinical Scientists, a Fellow of the National Academy of Clinical Biochemistry and a Diplomat of the European Academy of Allergology and Clinical Immunology. Dr. Li is also an Associate Member of the Early Detection Research Network at The National Cancer Institute (USA). He is an Adjunct Professor at the Hong Kong Polytechnic University. He has launched over 52 510K and PMA IVD products and 6 Instruments.

For more information visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thomas Li, Sr Director at Roche to Speak at 3rd Oncology Biomarkers Conference on January 27-28 San Diego, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today